FindTrial
Sign In

Prospective Intervention Trial of Real-World Study of KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets

Real-World Study of KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055275
Enrollment
Unknown
Registered
2022-01-05
Start date
2022-01-06
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Intervention group:KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets
Control group:Nil

Sponsors

Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the intervention group: (1) Willing to take KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets for 6 months; (2) Aged >= 18 years. 2. Inclusion criteria for the control group: (1) Have not taken and will not take KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets in the next 6 months; (2) Aged >= 18 years, willing to cooperate in completing the questionnaire or bone density test.

Exclusion criteria

Exclusion criteria: 1. Suffering from mental illness and unable to sign informed consent or complete the questionnaire; 2. Suffering from rheumatoid arthritis; 3. A history of joint surgery; 4. Patients of childbearing age who are pregnant, breastfeeding or unwilling to use birth control during the research process; 5. Have a history of gout.

Design outcomes

Primary

MeasureTime frame
Bone density;—

Secondary

MeasureTime frame
Osteoarthritis Index Scale;—

Countries

China

Contacts

Public ContactXia Min

Sun Yat-Sen University

xiamin@mail.sysu.edu.cn+86 20 87332433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026